| content | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Chronic myelomonocytic leukemia Classification and external resources |
|
| ICD-O: | M9945/3 |
|---|---|
| MeSH | D015477 |
Chronic myelomonocytic leukemia (CMML) is a form of leukemia featuring monocytosis.[1]
It has traditionally been considered a type of myelodysplastic syndrome, but has recently been classified by the World Health Organization in a "myelodysplastic/myeloproliferative" category of medical conditions.[2][3]
Some distinguish between myelodysplastic and myeloproliferative forms of CMML.[4]
See also
References
- ^ "Myelodysplastic/Myeloproliferative Diseases Treatment - National Cancer Institute".
- ^ Cortes J (2003). "CMML: a biologically distinct myeloproliferative disease". Curr. Hematol. Rep. 2 (3): 202-8. PMID 12901341.
- ^ Elliott MA (2006). "Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined". Best Pract Res Clin Haematol 19 (3): 571-93. doi:. PMID 16781489.
- ^ Voglová J, Chrobák L, Neuwirtová R, Malasková V, Straka L (2001). "Myelodysplastic and myeloproliferative type of chronic myelomonocytic leukemia--distinct subgroups or two stages of the same disease?". Leuk. Res. 25 (6): 493-9. PMID 11337023.
 |
This disease article is a stub. You can help Wikipedia by expanding it. |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
